-
1
-
-
0037364352
-
Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients
-
DOI 10.1200/JCO.2003.07.113
-
Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. J Clin Oncol 2003; 21: 897-906. (Pubitemid 46613489)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.5
, pp. 897-906
-
-
Armitage, J.O.1
Carbone, P.P.2
Connors, J.M.3
Levine, A.4
Bennett, J.M.5
Kroll, S.6
-
2
-
-
0033993572
-
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies
-
Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947-955. (Pubitemid 30123769)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.5
, pp. 947-955
-
-
Micallef, I.N.M.1
Lillington, D.M.2
Apostolidis, J.3
Amess, J.A.L.4
Neat, M.5
Matthews, J.6
Clark, T.7
Foran, J.M.8
Salam, A.9
Lister, T.A.10
Rohatiner, A.Z.S.11
-
3
-
-
0035183056
-
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
-
DOI 10.1016/S0145-2126(00)00092-8, PII S0145212600000928
-
Misgeld E, Germing U, Aul C, Gattermann N. Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma. Leuk Res 2001; 25: 95-98. (Pubitemid 32012986)
-
(2001)
Leukemia Research
, vol.25
, Issue.1
, pp. 95-98
-
-
Misgeld, E.1
Germing, U.2
Aul, C.3
Gattermann, N.4
-
4
-
-
0037106257
-
Therapy-related myeloid leukemia's are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
-
Morrison VA, Rai KR, Peterson BL, Kolitz JE, Appelbaum FR, Hines JD et al. Therapy-related myeloid leukemia's are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002; 20: 3878-3884.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3878-3884
-
-
Morrison, V.A.1
Rai, K.R.2
Peterson, B.L.3
Kolitz, J.E.4
Appelbaum, F.R.5
Hines, J.D.6
-
5
-
-
33750958028
-
Treatment-related myelodysplasia following fludarabine combination chemotherapy
-
Tam CS, Seymour JF, Prince HM, Kenealy M, Wolf M, Januszewicz EH et al. Treatment-related myelodysplasia following fludarabine combination chemotherapy. Haematologica 2006; 91: 1546-1550. (Pubitemid 44739896)
-
(2006)
Haematologica
, vol.91
, Issue.11
, pp. 1546-1550
-
-
Tam, C.S.1
Seymour, J.F.2
Prince, H.M.3
Kenealy, M.4
Wolf, M.5
Januszewicz, E.H.6
Westerman, D.7
-
6
-
-
4344660758
-
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
-
DOI 10.1200/JCO.2004.07.170
-
Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A et al. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. J Clin Oncol 2004; 22: 2654-2661. (Pubitemid 41103753)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.13
, pp. 2654-2661
-
-
Zinzani, P.L.1
Pulsoni, A.2
Perrotti, A.3
Soverini, S.4
Zaja, F.5
De Renzo, A.6
Storti, S.7
Lauta, V.M.8
Guardigni, L.9
Gentilini, P.10
Tucci, A.11
Molinari, A.L.12
Gobbi, M.13
Falini, B.14
Fattori, P.P.15
Ciccone, F.16
Alinari, L.17
Martelli, M.18
Pileri, S.19
Tura, S.20
Baccarani, M.21
more..
-
7
-
-
0029991369
-
Fludarabine, mitoxantrone, and dexamethasone: An effective new regimen for indolent lymphoma
-
McLaughlin P, Hagemeister FB, Romaguera JE, Sarris AH, Pate O, Younes A et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lym-phoma. J Clin Oncol 1996; 14: 1262-1268. (Pubitemid 26105534)
-
(1996)
Journal of Clinical Oncology
, vol.14
, Issue.4
, pp. 1262-1268
-
-
McLaughlin, P.1
Hagemeister, F.B.2
Romaguera, J.E.3
Sarris, A.H.4
Pate, O.5
Younes, A.6
Swan, F.7
Keating, M.8
Cabanillas, F.9
-
8
-
-
62449324950
-
Follicular lymphoma in the United States: First report of the national LymphoCare study
-
Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol 2009; 27: 1202-1208.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1202-1208
-
-
Friedberg, J.W.1
Taylor, M.D.2
Cerhan, J.R.3
Flowers, C.R.4
Dillon, H.5
Farber, C.M.6
-
9
-
-
0033002175
-
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients
-
DOI 10.1046/j.1365-2141.1999.01379.x
-
Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P et al. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukemia patients. Br J Haematol 1999; 105: 775-779. (Pubitemid 29277040)
-
(1999)
British Journal of Haematology
, vol.105
, Issue.3
, pp. 775-779
-
-
Visani, G.1
Lemoli, R.M.2
Tosi, P.3
Martinelli, G.4
Testoni, N.5
Ricci, P.6
Piccaluga, P.P.7
Pastano, R.8
Leopardi, G.9
Dizdari, A.10
Motta, M.R.11
Rizzi, S.12
Tura, S.13
-
10
-
-
9144222685
-
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
-
DOI 10.1182/blood-2003-05-1449
-
Tournilhac O, Cazin B, Lepretre S, Divine M, Maloum K, Delmer A et al. Impact of frontline fludarabine and cyclopho-sphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood 2004; 103: 363-365. (Pubitemid 38029961)
-
(2004)
Blood
, vol.103
, Issue.1
, pp. 363-365
-
-
Tournilhac, O.1
Cazin, B.2
Lepretre, S.3
Divine, M.4
Maloum, K.5
Delmer, A.6
Grosbois, B.7
Feugier, P.8
Maloisel, F.9
Villard, F.10
Villemagne, B.11
Bastit, D.12
Belhadj, K.13
Azar, N.14
Michallet, M.15
Manhes, G.16
Travade, P.17
-
11
-
-
0036015542
-
Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up
-
DOI 10.1038/sj.bmt.1703525
-
Bolwell B, Kalaycio M, Sobecks R, Andresen S, Mcbee M, Kuczkowski L et al. Autologous hematopoietic cell transplantation for non-Hodgkin's lymphoma: 100 month follow-up. Bone Marrow Transplant 2002; 29: 673-679. (Pubitemid 34591310)
-
(2002)
Bone Marrow Transplantation
, vol.29
, Issue.8
, pp. 673-679
-
-
Bolwell, B.J.1
Kalaycio, M.2
Sobecks, R.3
Andresen, S.4
Mcbee, M.5
Kuczkowski, L.6
Rybicki, L.7
Pohlman, B.8
-
12
-
-
33645116094
-
Treatment of follicular non-Hodgkin's lympho-ma
-
Maloney DG. Treatment of follicular non-Hodgkin's lympho-ma. Curr Hematol Rep 2005; 4: 39-45.
-
(2005)
Curr Hematol Rep
, vol.4
, pp. 39-45
-
-
Maloney, D.G.1
-
13
-
-
33747061875
-
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia
-
DOI 10.1200/JCO.2006.06.0673
-
Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E et al. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelo-dysplasia and acute myelogenous leukemia. J Clin Oncol 2006; 24: 3604-3610. (Pubitemid 46630533)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.22
, pp. 3604-3610
-
-
Kalaycio, M.1
Rybicki, L.2
Pohlman, B.3
Sobecks, R.4
Andresen, S.5
Kuczkowski, E.6
Bolwell, B.7
-
14
-
-
0028064764
-
A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
-
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392. (Pubitemid 24273002)
-
(1994)
Blood
, vol.84
, Issue.5
, pp. 1361-1392
-
-
Harris, N.L.1
Jaffe, E.S.2
Stein, H.3
Banks, P.M.4
Chan, J.K.C.5
Cleary, M.L.6
Delsol, G.7
De Wolf-Peeters, C.8
Falini, B.9
Gatter, K.C.10
Grogan, T.M.11
Isaacson, P.G.12
Knowles, D.M.13
Mason, D.Y.14
Muller-Hermelink, H.-K.15
Pileri, S.A.16
Piris, M.A.17
Ralfkiaer, E.18
Warnke, R.A.19
-
15
-
-
0033935703
-
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
-
Copelan EA, Penza SL, Pohlman B, Avalos BR, Goormastic M, Andresen SW et al. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2000; 25: 1243-1248. (Pubitemid 30428138)
-
(2000)
Bone Marrow Transplantation
, vol.25
, Issue.12
, pp. 1243-1248
-
-
Copelan, E.A.1
Penza, S.L.2
Pohlman, B.3
Avalos, B.R.4
Goormastic, M.5
Andresen, S.W.6
Kalaycio, M.7
Bechtel, T.P.8
Scholl, M.D.9
Elder, P.J.10
Ezzone, S.A.11
O'Donnell, L.C.12
Tighe, M.B.13
Risley, G.L.14
Young, D.C.15
Bolwell, B.J.16
-
16
-
-
0031938544
-
Delayed G-CSF after autologous progenitor cell transplantation: A prospective randomized trial
-
Bolwell BJ, Pohlman B, Andresen S, Kalaycio M, Goormastic M, Wise K et al. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial. Bone Marrow Transplant 1998; 21: 369-373. (Pubitemid 28080473)
-
(1998)
Bone Marrow Transplantation
, vol.21
, Issue.4
, pp. 369-373
-
-
Bolwell, B.J.1
Pohlman, B.2
Andresen, S.3
Kalaycio, M.4
Goormastic, M.5
Wise, K.6
Wakeling, A.7
Dannley, R.8
Overmoyer, B.9
-
17
-
-
0022135739
-
Proposed revised criteria for the classification of acute leukemia
-
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute leukemia. Ann Intern Med 1985; 103: 620-629.
-
(1985)
Ann Intern Med
, vol.103
, pp. 620-629
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.5
Gralnick, H.R.6
-
18
-
-
0034079462
-
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma
-
Saso R, Kulkarni S, Mitchell P, Treleaven J, Swansbury GJ, Mehta J et al. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 2000; 83: 91-94. (Pubitemid 30352723)
-
(2000)
British Journal of Cancer
, vol.83
, Issue.1
, pp. 91-94
-
-
Saso, R.1
Kulkarni, S.2
Mitchell, P.3
Treleaven, J.4
Swansbury, G.J.5
Mehta, J.6
Powles, R.7
Ashley, S.8
Kuan, A.9
Powles, T.10
-
19
-
-
2342524597
-
Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine [7]
-
DOI 10.1038/sj.leu.2403326
-
Morgan SJ, Seymour JF, Grigg A, Matthews JP, Prince HM, Wolf MM et al. Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. Leukemia 2004; 18: 1034-1038. (Pubitemid 38714635)
-
(2004)
Leukemia
, vol.18
, Issue.5
, pp. 1034-1038
-
-
Morgan, S.J.1
Seymour, J.F.2
Grigg, A.3
Matthews, J.P.4
Prince, H.M.5
Wolf, M.M.6
Januszewicz, E.H.7
-
20
-
-
40849151011
-
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study
-
DOI 10.3324/haematol.12120
-
Sacchi S, Marcheselli L, Bari A, Marcheselli R, Pozzi S, Gobbi PG et al. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93: 398-404. (Pubitemid 351398641)
-
(2008)
Haematologica
, vol.93
, Issue.3
, pp. 398-404
-
-
Sacchi, S.1
Marcheselli, L.2
Bari, A.3
Marcheselli, R.4
Pozzi, S.5
Luminari, S.6
Lombardo, M.7
Buda, G.8
Lazzaro, A.9
Gobbi, P.G.10
Stelitano, C.11
Morabito, F.12
Quarta, G.13
Brugiatelli, M.14
-
21
-
-
41049083911
-
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: The role of pre-transplant therapy
-
DOI 10.1111/j.1399-0012.2007.00768.x
-
Laurenti L, Tarnani M, Chiusolo P, La Torre G, Garzia M, Zollino M et al. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy. Clin Transplant 2008; 22: 191-199. (Pubitemid 351420013)
-
(2008)
Clinical Transplantation
, vol.22
, Issue.2
, pp. 191-199
-
-
Laurenti, L.1
Tarnani, M.2
Chiusolo, P.3
La Torre, G.4
Garzia, M.5
Zollino, M.6
Zini, G.7
Balducci, M.8
Leone, G.9
Sica, S.10
-
22
-
-
33745174485
-
High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders [4]
-
DOI 10.1111/j.1365-2141.2006.06158.x
-
Bowcock SJ, Rassam SM, Lim Z, Ward SM, Ryali MM, Mufti GJ. High incidence of therapy-related myelodysplasia and acute leukemia in general hematology clinic patients treated with fludarabine and cyclophosphamide for indolent lympho-proliferative disorders. Br J Haematol 2006; 134: 242-243. (Pubitemid 43893921)
-
(2006)
British Journal of Haematology
, vol.134
, Issue.2
, pp. 242-243
-
-
Bowcock, S.J.1
Rassam, S.M.B.2
Lim, Z.3
Ward, S.M.4
Ryali, M.M.5
Mufti, G.J.6
-
23
-
-
0035179950
-
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine
-
Yamauchi T, Nowak BJ, Keating MJ, Plunkett W. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludara-bine and clofarabine. Clin Cancer Res 2001; 7: 3580-3589. (Pubitemid 33069998)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.11
, pp. 3580-3589
-
-
Yamauchi, T.1
Nowak, B.J.2
Keating, M.J.3
Plunkett, W.4
-
24
-
-
0036659926
-
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: Protective effect of defibrotide
-
DOI 10.1182/blood.V100.1.334
-
Eissner G, Multhoff G, Gerbitz A, Kirchner S, Bauer S, Haffner S et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334-340. (Pubitemid 35177465)
-
(2002)
Blood
, vol.100
, Issue.1
, pp. 334-340
-
-
Eissner, G.1
Multhoff, G.2
Gerbitz, A.3
Kirchner, S.4
Bauer, S.5
Haffner, S.6
Sondermann, D.7
Andreesen, R.8
Holler, E.9
-
25
-
-
56249094143
-
Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization
-
Berger MG, Berger J, Richard C, Jeanpierre S, Nicolini FE, Tournilhac O et al. Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. Leukemia 2008; 22: 2131-2134.
-
(2008)
Leukemia
, vol.22
, pp. 2131-2134
-
-
Berger, M.G.1
Berger, J.2
Richard, C.3
Jeanpierre, S.4
Nicolini, F.E.5
Tournilhac, O.6
|